Alto Neuroscience, Inc.

ANRO · NYSE · SIC 2834: Pharmaceutical Preparations
39
SEC Filings

Business Summary

Part I . Overview We are a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Through insig hts derived from our scalable and proprietary Precision Psychiatry Platform, or our Platform, we aim to discover brain-based biomarkers to better identify which patients are more likely to respond to our novel product candidates. Our current pipeline consists of seven clinical-stage asset...

Next Earnings

Q2 FY2026 — expected 2026-08-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionANROdiscussed_in_filing Artificial Intelligence
topic_mentionANROdiscussed_in_filing Cybersecurity
topic_mentionANROdiscussed_in_filing Trusted Computing
topic_mentionANROdiscussed_in_filing Blockchain & Crypto
topic_mentionANROdiscussed_in_filing Capital Expenditure
topic_mentionANROdiscussed_in_filing Regulation
topic_mentionANROdiscussed_in_filing Healthcare & Bio
topic_mentionANROdiscussed_in_filing Platform & Ecosystem
topic_mentionANROdiscussed_in_filing Artificial Intelligence
topic_mentionANROdiscussed_in_filing Cybersecurity
topic_mentionANROdiscussed_in_filing Trusted Computing
topic_mentionANROdiscussed_in_filing Blockchain & Crypto
topic_mentionANROdiscussed_in_filing Capital Expenditure
topic_mentionANROdiscussed_in_filing Regulation
topic_mentionANROdiscussed_in_filing Healthcare & Bio
topic_mentionANROdiscussed_in_filing Platform & Ecosystem
topic_mentionANROdiscussed_in_filing Artificial Intelligence
topic_mentionANROdiscussed_in_filing Cybersecurity
topic_mentionANROdiscussed_in_filing Trusted Computing
topic_mentionANROdiscussed_in_filing Blockchain & Crypto

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-162025-12-310001999480-26-000002EDGAR122K words
2025-03-202024-12-310001999480-25-000025EDGAR—
2024-03-212023-12-310001999480-24-000010EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001999480-25-000090EDGAR25K words
2025-08-132025-06-300001999480-25-000076EDGAR—
2025-05-142025-03-310001999480-25-000037EDGAR—
2024-11-122024-09-300001999480-24-000042EDGAR—
2024-08-132024-06-300001999480-24-000035EDGAR—
2024-05-142024-03-310001999480-24-000022EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-010001104659-26-038593EDGAR1K words
2026-03-160001104659-26-027953EDGAR—
2026-03-160001999480-26-000001EDGAR—
2025-11-120001999480-25-000089EDGAR—
2025-10-200001104659-25-100801EDGAR—
2025-08-130001999480-25-000075EDGAR—
2025-07-080001999480-25-000061EDGAR—
2025-06-260001999480-25-000053EDGAR—
2025-06-030001999480-25-000048EDGAR—
2025-05-140001999480-25-000035EDGAR—

39 total filings indexed. 20 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001999480
TickerANRO
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c142e0870b59c59be3bfca17d1552a538aeddef623b202055feea4806f5970b3
parent: 84549443f40dcb7bbb8cd91024c957c02940b905b12b1e1808f174668f2abe1e
content hash: 3835b11086dd44f23c854ce64ac2620174e235b5b0a43548b72978c45f33b705
signed: 2026-04-13T04:43:39.847Z
sources: 9 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf